Keryx Biopharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Keryx Biopharmaceuticals's balance sheet done over the years? Its assets were worth $158,872,000 last year, which is more than in the previous period. 109% of Keryx Biopharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $172,967,000, which means an increase by 16% compared compared to last year.
Debt to Assets
| 2010 | 32114000 | 8.86M | 27.61% |
|---|---|---|---|
| 2011 | 43488000 | 12.44M | 28.61% |
| 2012 | 18569000 | 8.07M | 43.49% |
| 2013 | 60766000 | 15.36M | 25.29% |
| 2014 | 103628000 | 30.14M | 29.09% |
| 2015 | 258685000 | 171.75M | 66.39% |
| 2016 | 141427000 | 149.72M | 105.87% |
| 2017 | 158872000 | 172.96M | 108.87% |
KERX Balance Sheet (2010 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | 93.52M | 111.81M | 200.29M | 74.28M | 55.69M | 14.67M | 35.25M | 28.41M |
Short term investments | 0 | 0 | 0 | 11.50M | 0 | 0 | 4.21M | 100K |
Net receivables | 8.14M | 5.23M | 4.29M | 882K | 0 | 0 | 7K | 0 |
Inventory | 28.69M | 12.68M | 41.88M | 7.83M | 0 | 0 | 0 | 0 |
Other current assets | 11.19M | 3.17M | 2.83M | 4.09M | 1.23M | 430K | 534K | 200K |
Total current assets | 141.56M | 132.89M | 249.29M | 98.59M | 56.92M | 15.10M | 40.00M | 28.71M |
Non-current assets: | ||||||||
Property, Plant and Equipment | 4.52M | 4.21M | 5.08M | 1.53M | 349K | 56K | 67K | 57K |
Goodwill | 3.20M | 3.20M | 3.20M | 3.20M | 3.20M | 3.20M | 3.20M | 3.20M |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 9.57M | 1.11M | 1.1M | 292K | 281K | 198K | 209K | 0 |
Total non-current assets | 17.30M | 8.53M | 9.39M | 5.03M | 3.83M | 3.46M | 3.48M | 3.26M |
Total assets | 158.87M | 141.42M | 258.68M | 103.62M | 60.76M | 18.56M | 43.48M | 32.11M |
Liabilities | ||||||||
| Current liabilities: | ||||||||
Accounts payable | ||||||||
Deferred revenue | 0 | -105.79M | 3.52M | 414K | 0 | 0 | 0 | 156K |
Short term debt | 0 | 125M | 90.77M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 45.42M | 21.55M | 77.60M | 29.31M | 15.32M | 8.03M | 9.76M | 6.19M |
| Non-current liabilities: | ||||||||
Long term debt | 125M | 125M | 90.77M | 0 | 0 | 0 | 8.87M | 5.36M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 894K | 1.04M | 1.07M | 133K | 0 | 36K | -8.83M | 0 |
Total non-current liabilities | 127.54M | 128.17M | 94.14M | 833K | 38K | 36K | 35K | 5.36M |
Total liabilities | 172.96M | 149.72M | 171.75M | 30.14M | 15.36M | 8.07M | 12.44M | 8.86M |
| Data source | Data source |